Renasis Bio Ltd.

AI-Driven Drug Discovery Platform for RNA-Targeting Small Molecules

Biotechnology
Active
Rehovot, Israel Founded 2025
Website ↗
Last updated 2026-08-22
Total raised
Stage
Founded
2025
Headcount
HQ
Rehovot, Israel
Sector
Biotechnology

About

Renasis Bio is a stealth mode company that is developing an AI-Driven Drug Discovery Platform for RNA-Targeting Small Molecules. The company aims to advance biology through a tech-bio revolution.

Funding history · 1 round · — total

2025-05
Seed Undisclosed
★ Venture Studio★ High-Tech Company★ IVC Data & Insights

Q&A

What is Renasis Bio Ltd.'s primary focus?
Renasis Bio Ltd. is developing an AI-Driven Drug Discovery Platform for RNA-Targeting Small Molecules, aiming to advance biology through a tech-bio revolution.
When was Renasis Bio Ltd. founded?
Renasis Bio Ltd. was founded in 2025.
Where is Renasis Bio Ltd. headquartered?
Renasis Bio Ltd. is headquartered in Rehovot, Israel.
Which sector does Renasis Bio Ltd. primarily operate in?
Renasis Bio Ltd.'s primary sector is Biotechnology.
What type of funding round did Renasis Bio Ltd. complete in May 2025?
In May 2025, Renasis Bio Ltd. completed a Seed funding round.
Who are the co-founders of Renasis Bio Ltd.?
The co-founders of Renasis Bio Ltd. are Dalya Gartzman, who serves as CEO, and Dor Arieli, who serves as CTO.
What are the key technologies utilized by Renasis Bio Ltd.?
Renasis Bio Ltd. utilizes Artificial Intelligence, Computational Biology, and Deep Tech in its operations.
Which organization is Renasis Bio Ltd. affiliated with?
Renasis Bio Ltd. is a startup in AION Labs' portfolio.

Team · 2

Dalya Gartzman
Founder · CEO & Co-Founder
Dor Arieli
Founder · CTO & Co-Founder

Sectors & technology

Primary sector
Biotechnology
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiterenasis.bio

Identifiers & details

Legal nameRENASIS BIO LTD
Founded2025